AN2 Therapeutics, Inc. Shares Outstanding (Cover Page)
AN2 Therapeutics, Inc. (ANTX) had Shares Outstanding (Cover Page) of 37.74 million shares as of 2026-08-06, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-06: Entity Common Stock, Shares Outstanding 37.74M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 36.02M shares.
- 2026-03-10: Entity Common Stock, Shares Outstanding 35.94M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 27.40M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 37.74M shares 10-Q · filed 2026-08-11 |
| 2026-05-07 | 36.02M shares 10-Q · filed 2026-05-11 |
| 2026-03-10 | 35.94M shares 10-K · filed 2026-03-17 |
| 2025-11-03 | 27.40M shares 10-Q · filed 2025-11-12 |
| 2025-08-04 | 27.33M shares 10-Q · filed 2025-08-12 |
| 2025-05-05 | 30.18M shares 10-Q · filed 2025-05-13 |
| 2025-03-20 | 30.10M shares 10-K · filed 2025-03-25 |
| 2024-11-06 | 29.88M shares 10-Q · filed 2024-11-13 |
| 2024-08-05 | 29.84M shares 10-Q · filed 2024-08-13 |
| 2024-05-06 | 29.83M shares 10-Q · filed 2024-05-14 |
| 2024-03-22 | 29.77M shares 10-K/A · filed 2024-05-14 |
| 2023-11-02 | 29.74M shares 10-Q · filed 2023-11-09 |
| 2023-08-04 | 21.93M shares 10-Q · filed 2023-08-10 |
| 2023-05-04 | 19.43M shares 10-Q · filed 2023-05-11 |
| 2023-03-22 | 19.40M shares 10-K · filed 2023-03-29 |
| 2022-11-02 | 19.40M shares 10-Q · filed 2022-11-09 |
| 2022-08-08 | 19.40M shares 10-Q · filed 2022-08-11 |
| 2022-05-06 | 19.40M shares 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |